keyword
https://read.qxmd.com/read/38647500/who-won
#1
JOURNAL ARTICLE
Srirama Srikanth
This poem describes the ugly face of misinformation and lies-spewing bile as COVID shook us and humanity came undone. Vaccines were rejected and lockdowns were broken. We barely withstood. Who won? No one. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
March 2024: Families, Systems & Health: the Journal of Collaborative Family Healthcare
https://read.qxmd.com/read/38646688/the-clinical-and-immunological-features-of-alopecia-areata-following-sars-cov-2-infection-or-covid-19-vaccines
#2
REVIEW
Shiqi Fu, Xiuzu Song
INTRODUCTION: Alopecia areata (AA) is an autoimmune disease induced by viral infection or vaccination. With the increased incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the incidence of AA has also increased. Recently the incidence was found to be 7.8% from a previously reported rate of 2.1%. The physical and psychological damage caused by AA could seriously affect patients' lives, while AA is a challenging dermatological disease owing to its complex pathogenesis...
April 22, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38646044/resilience-to-emerging-infectious-diseases-and-the-importance-of-scientific-innovation
#3
JOURNAL ARTICLE
Catherine Wilson, Emma C Thomson
This opinion piece emphasies the critical role of translational research in enhancing the UK's resilience against future pandemics. The COVID-19 pandemic demonstrated the lifesaving potential of scientific innovation, including genomic tracking of SARS-CoV-2, vaccine development, data linkage, modelling, and new treatments. These advances, achieved through collaborations between academic institutions, industry, government, public health bodies, and the NHS, occurred at an unprecedented pace. However, the UK's pandemic preparedness planning, as reflected in the 2016 Exercise Cygnus report, notably lacked provision for scientific innovation...
March 2024: Future Healthcare Journal
https://read.qxmd.com/read/38646017/obstacles-in-basic-health-service-when-dealing-with-covid-19-a-reflection-for-improvement
#4
JOURNAL ARTICLE
Putri Chairani Eyanoer, Fotarisman Zaluchu
BACKGROUND & AIMS: COVID-19 has been in control since mass vaccination and other coordinated efforts have been conducted. The WHO has even made an announcement to stop the public health emergency of international concern (PHEIC) toward COVID-19. Because of the very massive impacts of COVID-19, it is necessary to have a reflection toward what we have gone through to obtain information from inside the health service by interviewing the health officers who were the frontliners in fighting the disease during the pandemic...
2024: Journal of Multidisciplinary Healthcare
https://read.qxmd.com/read/38644708/navigating-the-alzheimer-s-treatment-landscape-unraveling-amyloid-beta-complexities-and-pioneering-precision-medicine-approaches
#5
JOURNAL ARTICLE
Mohsina Patwekar, Faheem Patwekar, Shahzad Khan, Rohit Sharma, Dileep Kumar
A variety of cutting-edge methods and good knowledge of the illness's complex causes are causing a sea change in the field of Alzheimer's Disease (A.D.) research and treatment. Precision medicine is at the vanguard of this change, where individualized treatment plans based on genetic and biomarker profiles give a ray of hope for customized therapeutics. Combination therapies are becoming increasingly popular as a way to address the multifaceted pathology of Alzheimer's by simultaneously attacking Aβ plaques, tau tangles, neuroinflammation, and other factors...
April 19, 2024: Current Topics in Medicinal Chemistry
https://read.qxmd.com/read/38644655/the-future-of-cancer-vaccines-against-colorectal-cancer
#6
REVIEW
Wenqing Jia, Xiaonan Shen, Zichao Guo, Xi Cheng, Ren Zhao
INTRODUCTION: Colorectal cancer (CRC) is the second most lethal malignancy worldwide. Immune checkpoint inhibitors (ICIs) benefit only 15% of patients with mismatch repair-deficient/microsatellite instability (dMMR/MSI) CRC. The majority of patients are not suitable due to insufficient immune infiltration. Cancer vaccines are a potential approach for inducing tumor-specific immunity within the solid tumor microenvironment. AREA COVERED: In this review, we have provided an overview of the current progress in CRC vaccines over the past three years and briefly depict promising directions for further exploration...
April 21, 2024: Expert Opinion on Biological Therapy
https://read.qxmd.com/read/38643898/stabilization-of-an-infectious-enveloped-virus-by-spray-drying-and-lyophilization
#7
JOURNAL ARTICLE
Holly Coleman, Daniel K Schwartz, Joel L Kaar, Robert L Garcea, Theodore W Randolph
Enveloped viruses are attractive candidates for use as gene- and immunotherapeutic agents due to their efficacy at infecting host cells and delivering genetic information. They have also been used in vaccines as potent antigens to generate strong immune responses, often requiring fewer doses than other vaccine platforms as well as eliminating the need for adjuvants. However, virus instability in liquid formulations may limit their shelf life and require that these products be transported and stored under stringently controlled temperature conditions, contributing to high cost and limiting patient access...
April 19, 2024: Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38643839/fusobacterium-nucleatum-carcinogenesis-and-drug-delivery-interventions
#8
REVIEW
Zhenzhen Chen, Leaf Huang
The microbiome has emerged as a significant biomarker and modulator in cancer development and treatment response. Recent research highlights the notable role of Fusobacterium nucleatum (F. nucleatum) in various tumor types, including breast, colorectal, esophageal, gastric, pancreatic, and lung cancers. Accumulating evidence suggests that the local microbial community forms an integral component of the tumor microenvironment, with bacterial communities within tumors displaying specificity to tumor types. Mechanistic investigations indicate that tumor-associated microbiota can directly influence tumor initiation, progression, and responses to chemotherapy or immunotherapy...
April 19, 2024: Advanced Drug Delivery Reviews
https://read.qxmd.com/read/38643811/prolonged-delivery-of-hiv-1-vaccine-nanoparticles-from-hydrogels
#9
JOURNAL ARTICLE
Raphael Mietzner, Clara Barbey, Heike Lehr, Christian E Ziegler, David Peterhoff, Ralf Wagner, Achim Goepferich, Miriam Breunig
Immunization is a straightforward concept but remains for some pathogens like HIV-1 a challenge. Thus, new approaches towards increasing the efficacy of vaccines are required to turn the tide. There is increasing evidence that antigen exposure over several days to weeks induces a much stronger and more sustained immune response compared to traditional bolus injection, which usually leads to antigen elimination from the body within a couple of days. Therefore, we developed a poly(ethylene) glycol (PEG) hydrogel platform to investigate the principal feasibility of a sustained release of antigens to mimic natural infection kinetics...
April 19, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38642254/bacterial-extracellular-vesicles-biotechnological-perspective-for-enhanced-productivity
#10
REVIEW
Laura M Muñoz-Echeverri, Santiago Benavides-López, Otto Geiger, Mauricio A Trujillo-Roldán, Norma A Valdez-Cruz
Bacterial extracellular vesicles (BEVs) are non-replicative nanostructures released by Gram-negative and Gram-positive bacteria as a survival mechanism and inter- and intraspecific communication mechanism. Due to BEVs physical, biochemical, and biofunctional characteristics, there is interest in producing and using them in developing new therapeutics, vaccines, or delivery systems. However, BEV release is typically low, limiting their application. Here, we provide a biotechnological perspective to enhance BEV production, highlighting current strategies...
April 20, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38641182/unveiling-clinical-applications-of-bacterial-extracellular-vesicles-as-natural-nanomaterials-in-disease-diagnosis-and-therapeutics
#11
REVIEW
Chun Liu, Negar Yazdani, Corey S Moran, Carlos Salomon, Chaminda Jayampath Seneviratne, Sašo Ivanovski, Pingping Han
Bacterial extracellular vesicles (BEVs) are naturally occurring bioactive membrane-bound nanoparticles released by both gram-negative and positive bacterial species, exhibiting a multifaceted role in mediating host-microbe interactions across various physiological conditions. Increasing evidence supports BEVs as essential mediators of intercellular exchange, influencing bacterial pathogenicity, disease mechanisms, and modulating the host immune response. However, the extent to which these BEV-mediated actions can be leveraged to predict disease onset, guide treatment strategies, and determine clinical outcomes remains uncertain, particularly in terms of their clinical translation potentials...
April 17, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38641002/pediatric-vaccination-outside-of-the-medical-home-updates-on-alternative-settings-for-vaccine-delivery
#12
REVIEW
Mersine A Bryan, Shannon H Baumer-Mouradian, Annika M Hofstetter
No abstract text is available yet for this article.
April 17, 2024: Academic Pediatrics
https://read.qxmd.com/read/38640729/preparation-and-brain-targeting-effects-study-of-recombinant-human-ferritin-nanoparticles
#13
JOURNAL ARTICLE
Zhixian Wang, Xiaoling Xu, Yunhuan Zhu, Yuncheng Qian, Yilu Feng, Hongyu Li, Guoheng Hu
Human heavy-chain ferritin is a naturally occurring protein with high stability and multifunctionality in biological systems. This study aims to utilize a prokaryotic expression system to produce recombinant human heavy-chain ferritin nanoparticles and investigate their targeting ability in brain tissue. The human heavy-chain ferritin gene was cloned into the prokaryotic expression vector pET28a and transformed into Escherichia coli BL21 (DE3) competent cells to explore optimal expression conditions. The recombinant protein was then purified to evaluate its immunoreactivity and characteristics...
April 15, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38640442/single-cell-oral-delivery-platform-for-enhanced-acid-resistance-and-intestinal-adhesion
#14
JOURNAL ARTICLE
Guangmin Wei, Moon Tay Yue Feng, Zhangyong Si, Mary B Chan-Park
Oral delivery of cells, such as probiotics and vaccines, has proved to be inefficient since cells are generally damaged in an acidic stomach prior to arrival at the intestine to exert their health benefits. In addition, short retention in the intestine is another obstacle which affects inefficiency. To overcome these obstacles, a cell-in-shell structure was designed with pH-responsive and mucoadhesive properties. The pH-responsive shell consisting of three cationic layers of chitosan and three anionic layers of trans -cinnamic acid ( t -CA) was made via layer-by-layer (LbL) assembly...
April 19, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38639270/recombinant-ace2-opportunities-and-challenges-in-covid-19-treatment
#15
JOURNAL ARTICLE
Rahul Sandhu, Mandeep Kaur, Akriti Aggarwal
It was in 2019 that the world experienced the devastation caused by SARS-COV-2, contributing to a large number of deaths. This contagious virus not only challenged the health care system but has also hit the economy very badly. There has been a lot of research on effective vaccine development, and there has been some success in the same, but no effective antiviral drugs are available in the market. No doubt vaccination can prevent the disease, but it doesn't have the potential to cure an infected person, for which there is a dire need to develop some effective drug...
April 18, 2024: Infectious Disorders Drug Targets
https://read.qxmd.com/read/38638642/cross-sectional-united-kingdom-surveys-demonstrate-that-owners-and-veterinary-professionals-differ-in-their-perceptions-of-preventive-and-treatment-healthcare-needs-in-ageing-dogs
#16
JOURNAL ARTICLE
Lisa J Wallis, Alan D Radford, Zoe Belshaw, Jodie Jackson, Eniko Kubinyi, Alexander J German, Carri Westgarth
Perceptions of dog owners and veterinary professionals (surgeons/nurses) can influence the preventive healthcare and treatment provided to dogs, especially at the senior life-stage, when chronic diseases become more common. This study compared perceptions of healthcare of dogs as they age between dog owners and veterinary professionals. Data from two online surveys (owners: N  = 633, veterinary professionals: N  = 305) examined perceived need for veterinary visits and vaccinations...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38635730/patients-knowledge-about-dental-emergencies-covid-19-transmission-and-required-preparations-in-dental-settings
#17
JOURNAL ARTICLE
Mohammad Reza Khami, Mahsa Karimi, Morenike Oluwatoyin Folayan, Ahmad Reza Shamshiri, Heikki Murtomaa
INTRODUCTION: The Coronavirus disease 2019 (COVID-19) pandemics negatively affected the delivery of dental care. The study objective was to assess the knowledge of emergency dental treatments, the transmission routes of COVID-19 in the dental settings, necessary precautions to prevent disease transmission, and the associations between demographic factors and the mentioned domains among Iranian dental patients. METHODS: This was a cross-sectional study conducted in October 2021...
2024: PloS One
https://read.qxmd.com/read/38631019/orchestrated-codelivery-of-peptide-antigen-and-adjuvant-to-antigen-presenting-cells-by-using-an-engineered-chimeric-peptide-enhances-antitumor-t-cell-immunity
#18
JOURNAL ARTICLE
Haifeng Pan, Siyuan Yu, Haoyun Zhuang, Han Yang, Jinlu Jiang, Haihui Yang, Shuling Ren, Guoxing Luo, Xuan Yu, Shuping Chen, Yanhua Lin, Roufang Sheng, Shiyin Zhang, Quan Yuan, Chenghao Huang, Tianying Zhang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia
The intrinsic pharmacokinetic limitations of traditional peptide-based cancer vaccines hamper effective cross-presentation and codelivery of antigens and adjuvants, which are crucial for inducing robust antitumor CD8+ T-cell responses. Here, we report the development of a versatile strategy that simultaneously addresses the different pharmacokinetic challenges of soluble subunit vaccines composed of antigens and CpG to modulate vaccine efficacy via translating an engineered chimeric peptide, eTAT, as an intramolecular adjuvant...
April 17, 2024: Cancer Immunology Research
https://read.qxmd.com/read/38630829/dual-responsive-nanocarriers-for-efficient-cytosolic-protein-delivery-and-crispr-cas9-gene-therapy-of-inflammatory-skin-disorders
#19
JOURNAL ARTICLE
Echuan Tan, Tao Wan, Qi Pan, Jianan Duan, Song Zhang, Ruijue Wang, Peng Gao, Jia Lv, Hui Wang, Dali Li, Yuan Ping, Yiyun Cheng
Developing protein drugs that can target intracellular sites remains a challenge due to their inadequate membrane permeability. Efficient carriers for cytosolic protein delivery are required for protein-based drugs, cancer vaccines, and CRISPR-Cas9 gene therapies. Here, we report a screening process to identify highly efficient materials for cytosolic protein delivery from a library of dual-functionalized polymers bearing both boronate and lipoic acid moieties. Both ligands were found to be crucial for protein binding, endosomal escape, and intracellular protein release...
April 19, 2024: Science Advances
https://read.qxmd.com/read/38630135/intratumor-injection-of-bcg-ag85a-high-affinity-peptides-enhanced-anti-tumor-efficacy-in-ppd-positive-melanoma
#20
JOURNAL ARTICLE
Lanqun Qin, Guiying Zhang, Yirong Wu, Yueling Yang, Zhengyun Zou
As one of the scheduled immunization vaccines worldwide, virtually all individuals have been vaccinated with BCG vaccine. In order to verify the hypothesis that delivering BCG high-affinity peptides to tumor areas could activate the existing BCG memory T cells to attack tumor, we firstly predicted the HLA-A*0201 high-affinity peptides of BCG Ag85A protein (KLIANNTRV, GLPVEYLQV), and then, A375 melanoma cells and HLA-A*0201 PBMCs (from PPD-positive adults) were added to co-incubated with the predicted peptides in vitro...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
keyword
keyword
52489
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.